Coronary and Structural Interventions Ulm - Coronary Chronic Total Occlusions
NCT ID: NCT02162082
Last Updated: 2020-04-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
198 participants
INTERVENTIONAL
2014-06-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factors and Outcomes in Coronary Chronic Total Occlusion
NCT06137521
Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries
NCT01924962
Chronic Total Coronary Occlusion Treatment Results 6 Years After Bioresorbable Scaffold Implantation
NCT06164977
Molecular and Cellular Mechanisms of the In-stent-thrombosis
NCT00652015
Ultrasonic Cardiogram Evaluate the Prognosis of Percutaneous Revascularization of Chronic Total Occlusions
NCT03300011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
stent or scaffold
implantation of stents or scaffolds after recanalization of coronary chronic total occlusions
stent or scaffold
implantation of a CE certified drug-eluting stent, bare-metal stent or scaffold
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
stent or scaffold
implantation of a CE certified drug-eluting stent, bare-metal stent or scaffold
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* chronic total occlusion
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ulm
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jochen Wohrle
Prof. Dr. Jochen Wöhrle
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jochen Wöhrle, MD
Role: PRINCIPAL_INVESTIGATOR
University of Ulm, Ulm, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ulm
Ulm, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kugler C, Markovic S, Rottbauer W, Wohrle J. Bioresorbable scaffolds compared with everolimus-eluting stents for the treatment of chronic coronary total occlusion: clinical and angiographic results of a matched paired comparison. Coron Artery Dis. 2017 Mar;28(2):120-125. doi: 10.1097/MCA.0000000000000449.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CSI Ulm - CTO 1.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.